Hepatic metastases in ovarian cancer

查看全文 作　　者：Ying [1]Shan;Ying [1]Jin;Lingya [1]Pan 机构地区：[1]Department of Obstetrics and Gynecology,National Clinical Research Center for Obstetric&Gynecologic Diseases,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing,China 出　　处：《Hepatobiliary Surgery and Nutrition》索引2022年第11卷第6期,共3页 基　　金：This work is supported by National High Level Hospital Clinical Research Funding 2022-PUMCH-C-045. 摘　　要：Ovarian cancer is the most lethal disease among gynecologic malignancies(1);about 1/4 of ovarian cancer patients are in stage IV when diagnosed.For ovarian epithelial cancer patients with stage IV disease,the mean overall survival(OS)is around 20 months,and the 5 year-OS is about 20%.About 1 in 5 patients with advanced-stage ovarian cancer have hepatobiliary involvement. 关 键 词：CANCER INVOLVEMENT PATIENTS